Safety and Efficacy of KY1044 and Atezolizumab in Advanced Cancer
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Squamous Cell Carcinoma of Head and Neck|Non-small Cell Lung Cancer|Hepatocellular Carcinoma|Esophageal Cancer|Gastric Cancer|Melanoma|Renal Cell Carcinoma|Pancreatic Cancer|Cervical Cancer|Triple Negative Breast Cancer|Advanced Cancer|Metastatic Cancer
Interventions: DRUG: KY1044|DRUG: KY1044 and atezolizumab
Sponsor: Kymab Limited
Collaborators: Sanofi